Survival of hemopoietic progenitors in the G0 period of the cell cycle does not require early hemopoietic regulators
- PMID: 2471971
- PMCID: PMC287305
- DOI: 10.1073/pnas.86.12.4535
Survival of hemopoietic progenitors in the G0 period of the cell cycle does not require early hemopoietic regulators
Abstract
Although it is generally held that hemopoietic stem cells in steady-state marrow are dormant in the cell cycle, the direct proof for this concept has been lacking. In the present study, we have documented the development of human multipotential blast cell colonies from single cells by daily observation of the growth of candidate progenitors. The results clearly demonstrated that early hemopoietic progenitors may remain as single cells for more than 2 weeks of incubation. Once the progenitors began proliferation, the subsequent growth was characterized by steady cell doubling. Next, we tested the survival of blast cell colony progenitors in the presence of neutralizing antibodies prepared against early acting hemopoietic factors including interleukin (IL) 1 alpha, IL-1 beta, IL-3, IL-6, and granulocyte colony-stimulating factor. Cultures were initiated with individual antibodies, and, on day 14, IL-3 and the corresponding growth factor in concentrations that neutralize the antibodies were added. On days 18-27 of culture, blast cell colonies containing 25 or more cells were identified and replated for analysis of their ability to form secondary colonies. The cumulative frequency of the blast cell colonies in cultures containing antibody did not differ significantly from that of the control group containing rabbit IgG. A combination of anti-IL-1 alpha, anti-IL-1 beta, anti-IL-6, and anti-granulocyte colony-stimulating factor did not affect the survival of dormant blast cell colony-forming cells. These results indicate that survival of hemopoietic stem cells in the G0 period of the cell cycle is independent of early hemopoietic regulators.
Similar articles
-
Murine B-cell stimulatory factor-1 (BSF-1)/interleukin-4 (IL-4) is a multilineage colony-stimulating factor that acts directly on primitive hemopoietic progenitors.J Cell Physiol. 1989 Jun;139(3):463-8. doi: 10.1002/jcp.1041390303. J Cell Physiol. 1989. PMID: 2786878
-
Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor.Blood. 1988 Dec;72(6):2007-14. Blood. 1988. PMID: 3264195
-
gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2859-63. doi: 10.1073/pnas.92.7.2859. Proc Natl Acad Sci U S A. 1995. PMID: 7535932 Free PMC article.
-
Effects of hemopoietic growth factors on stem cells in vitro.Hematol Oncol Clin North Am. 1989 Sep;3(3):453-64. Hematol Oncol Clin North Am. 1989. PMID: 2698877 Review.
-
Hemopoietic stem cells: stochastic differentiation and humoral control of proliferation.Environ Health Perspect. 1989 Mar;80:199-207. doi: 10.1289/ehp.8980199. Environ Health Perspect. 1989. PMID: 2647480 Free PMC article. Review.
Cited by
-
Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors.Proc Natl Acad Sci U S A. 1992 May 1;89(9):4013-7. doi: 10.1073/pnas.89.9.4013. Proc Natl Acad Sci U S A. 1992. PMID: 1373892 Free PMC article.
-
A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis.J Clin Invest. 1994 Jul;94(1):320-7. doi: 10.1172/JCI117324. J Clin Invest. 1994. PMID: 8040273 Free PMC article.
-
Stem cell origins of leukaemia and curability.Br J Cancer. 1993 Mar;67(3):413-23. doi: 10.1038/bjc.1993.81. Br J Cancer. 1993. PMID: 8439493 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials